Structure Therapeutics Inc. - ROE
GPCR
Price:
$44.51
Market Cap:
$2.56B
Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressin...[Read more]
Industry
Biotechnology
IPO Date
2023-02-03
Stock Exchange
NASDAQ
Ticker
GPCR
PE Ratio
[-16.86]
ROE
[-15.14%]
Current Ratio
[26.16]
Dividend Yield
[0%]
Enterprise Value
[2.25B]
Dividend History
The ROE as of June 2026 (TTM) for Structure Therapeutics Inc. (GPCR) is -15.14%
According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -15.14%. This represents a change of 208.89% compared to the average of -4.90% of the last 4 quarters.
Structure Therapeutics Inc. (GPCR) Historical ROE (quarterly & annually)
How has GPCR ROE performed in the past?
The mean historical ROE of Structure Therapeutics Inc. over the last ten years is 22.32%. The current -15.14% ROE has changed -167.86% with respect to the historical average. Over the past ten years (40 quarters), GPCR's ROE was at its highest in in the September 2022 quarter at 11.95%. The ROE was at its lowest in in the September 2023 quarter at -12.37%.
Average
22.32%
Median
17.63%
Minimum
-19.79%
Maximum
70.78%
Structure Therapeutics Inc. (GPCR) ROE by Quarter and Year
Discovering the peaks and valleys of Structure Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 70.78%
Minimum Annual Increase = -144.39%
Minimum Annual ROE = -19.79%
| Year | ROE | Change |
|---|---|---|
| 2025 | -9.31% | -34.27% |
| 2024 | -14.17% | -28.39% |
| 2023 | -19.79% | -144.39% |
| 2022 | 44.57% | -27.88% |
| 2021 | 61.80% | -12.68% |
Structure Therapeutics Inc. (GPCR) Average ROE
How has GPCR ROE performed in the past?
The current ROE of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.42%
5-year avg
12.62%
10-year avg
22.32%
Structure Therapeutics Inc. (GPCR) ROE vs. Peers
How is GPCR’s ROE compared to its peers?
Structure Therapeutics Inc.’s ROE is greater than Edgewise Therapeutics, Inc. (-32.55%), greater than Viridian Therapeutics, Inc. (-60.70%), greater than uniQure N.V. (-145.81%), greater than Ocular Therapeutix, Inc. (-64.55%), greater than Nuvation Bio Inc. (-44.10%), less than Galapagos N.V. (16.88%), greater than Mesoblast Limited (-14.02%), less than Liquidia Corporation (46.82%), greater than Celldex Therapeutics, Inc. (-50.72%), greater than AbCellera Biologics Inc. (-14.86%),
| Company | ROE | Market cap |
|---|---|---|
| -32.55% | $3.96B | |
| -60.70% | $1.50B | |
| -145.81% | $2.92B | |
| -64.55% | $2.06B | |
| -44.10% | $1.93B | |
| 16.88% | $1.84B | |
| -14.02% | $1.86B | |
| 46.82% | $6.32B | |
| -50.72% | $2.16B | |
| -14.86% | $1.69B |
Build a custom stock screener for Structure Therapeutics Inc. (GPCR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Structure Therapeutics Inc. (GPCR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Structure Therapeutics Inc.'s ROE?
How is the ROE calculated for Structure Therapeutics Inc. (GPCR)?
What is the highest ROE for Structure Therapeutics Inc. (GPCR)?
What is the 3-year average ROE for Structure Therapeutics Inc. (GPCR)?
What is the 5-year average ROE for Structure Therapeutics Inc. (GPCR)?
How does the current ROE for Structure Therapeutics Inc. (GPCR) compare to its historical average?